Identification and characterization of calcium binding protein, spermatid-associated 1 (CABS1)# in selected human tissues and fluids

PLoS One. 2024 May 16;19(5):e0301855. doi: 10.1371/journal.pone.0301855. eCollection 2024.

Abstract

Calcium binding protein, spermatid associated 1 (CABS1) is a protein most widely studied in spermatogenesis. However, mRNA for CABS1 has been found in numerous tissues, albeit with little information about the protein. Previously, we identified CABS1 mRNA and protein in human salivary glands and provided evidence that in humans CABS1 contains a heptapeptide near its carboxyl terminus that has anti-inflammatory activities. Moreover, levels of an immunoreactive form of CABS1 were elevated in psychological stress. To more fully characterize human CABS1 we developed additional polyclonal and monoclonal antibodies to different sections of the protein and used these antibodies to characterize CABS1 in an overexpression cell lysate, human salivary glands, saliva, serum and testes using western blot, immunohistochemistry and bioinformatics approaches exploiting the Gene Expression Omnibus (GEO) database. CABS1 appears to have multiple molecular weight forms, consistent with its recognition as a structurally disordered protein, a protein with structural plasticity. Interestingly, in human testes, its cellular distribution differs from that in rodents and pigs, and includes Leydig cells, primary spermatogonia, Sertoli cells and developing spermatocytes and spermatids, Geodata suggests that CABS1 is much more widely distributed than previously recognized, including in the urogenital, gastrointestinal and respiratory tracts, as well as in the nervous system, immune system and other tissues. Much remains to be learned about this intriguing protein.

MeSH terms

  • Animals
  • Calcium-Binding Proteins* / genetics
  • Calcium-Binding Proteins* / metabolism
  • Humans
  • Male
  • Saliva / metabolism
  • Salivary Glands / metabolism
  • Spermatids / metabolism
  • Spermatogenesis
  • Testis* / metabolism

Grants and funding

MMP, RGPIN-2020-04553, Natural Sciences and Engineering Research Council of Canada, https://www.nserc-crsng.gc.ca/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ADB, 16BB-MSI-C5 and 18BB-SI-C9. AllerGen. https://www.allergen.ca/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GB Diagnostics, 10515302 Canada Inc. provided funding within the company for characterization of the polyclonal and monoclonal antibodies to human CABS1 and for their long term storage. Drs Buck and Gonshor, co-owners of GB Diagnostics contributed to design of the monoclonal antibodies and analysis of their specificities, as well as to discussions about the preparation of the manuscript and its editing. Stephen Lewis and Michiko Watanabe have no funding to declare.